Executive Series 26 Jun 18: Wattle Health Australia (WHA) CEO, Lazarus Karasavvidis, page-58

sales was 71% over 2017, so total sale is $1,587,608.46c for financial year.

this means Q4 total sales was $121,928.46 down from Q3of $804,379.


Totally abysmal after API and MET's orders. Going by that I dont think API will be topping up any time soon. In fact give it 6 months there will be massive clearances to get rid of short dated stock

the market is not reacting to the fundamentals or the cash flow. its a disaster.

its reating the one paragraph "The initial term under the Agreement is for 42 months (initial period) with minimum guaranteed volumes, resulting in $100 millionin revenueover the initial period.
The Agreement is subject to WHA obtaining SAMR accreditation and finalisation of the formal supply agreement."

again everything is a gamble, because its not sales that drives this company. it little snippets from Laz, George and Peter. Spin kings better than Shane Warne.